Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron, Robert J. Tombari, Ju Lu, et al.
Nature (2020) Vol. 589, Iss. 7842, pp. 474-479
Open Access | Times Cited: 335

Showing 1-25 of 335 citing articles:

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao, Clara Liao, Ian Gregg, et al.
Neuron (2021) Vol. 109, Iss. 16, pp. 2535-2544.e4
Open Access | Times Cited: 367
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 259
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Maxemiliano V. Vargas, Lee E. Dunlap, Chunyang Dong, et al.
Science (2023) Vol. 379, Iss. 6633, pp. 700-706
Open Access | Times Cited: 242
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 563-567
Open Access | Times Cited: 237
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
Manoj K. Doss, Michal Považan, Monica D. Rosenberg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 228
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 6, pp. 1032-1041
Open Access | Times Cited: 225
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao, Jing Yu, Huan Wang, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 403-411
Closed Access | Times Cited: 211
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga, Bohan Zhu, Christopher A. Guevara, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109836-109836
Open Access | Times Cited: 147
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 140
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong, Calvin Ly, Lee E. Dunlap, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2779-2792.e18
Open Access | Times Cited: 139
The promises and perils of psychedelic pharmacology for psychiatry
Tristan McClure‐Begley, Bryan L. Roth
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 463-473
Closed Access | Times Cited: 139
Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling
Youying Zhang, Qilin Fan, Yuanlong Hou, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 11-22
Closed Access | Times Cited: 123
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 77
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
Vern Lewis, Emma M. Bonniwell, Janelle K. Lanham, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112203-112203
Open Access | Times Cited: 68
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 351-358
Open Access | Times Cited: 56
Psilocybin desynchronizes the human brain
Joshua S. Siegel, S. V. Subramanian, Demetrius Perry, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 131-138
Open Access | Times Cited: 55
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B. Cao, Maggie M. Calkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behavior
Lingsha Cheng, Haoqian Wu, Xiaoying Cai, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 227-243.e6
Open Access | Times Cited: 34
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Structural pharmacology and therapeutic potential of 5-methoxytryptamines
Audrey L. Warren, David Lankri, Michael J. Cunningham, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 237-246
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top